GRFS
Grifols, S.A.
GRFS trails on the overall score without a compensating advantage in the available component scores.
LLY
Eli Lilly and Company
LLY has the edge over GRFS overall, supported by stronger fundamentals and stronger modeled upside.
GRFS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Stable | |
| Weak |
GRFS's profitability is currently strong, and its revenue and cash flow are stable, but its balance sheet is weak.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
GRFS PE Valuation
GRFS has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
GRFS Forward outlook
There aren't enough analyst estimates for GRFS to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
GRFS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.74 | +54% |
| Q1 2026 | $0.68 | +113% |
| Q4 2025 | $0.65 | +160% |
| Q3 2025 | $0.61 | +165% |
| Q2 2025 | $0.48 | +100% |
| Q1 2025 | $0.32 | +10% |
| Q4 2024 | $0.25 | +8.7% |
| Q3 2024 | $0.23 | +28% |
GRFS's earnings per share have fallen from their peak: $0.74 over the past year, against $1.27 in mid-2021.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over GRFS on earnings, with stronger typical year-over-year growth.
GRFS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.1B | -0.9% |
| Q1 2026 | $1.9B | -3.2% |
| Q4 2025 | $2.2B | -0.6% |
| Q3 2025 | $2.1B | +4% |
| Q2 2025 | $2.1B | +4% |
| Q1 2025 | $2B | +9.8% |
| Q4 2024 | $2.2B | +12% |
| Q3 2024 | $2B | +12% |
GRFS's revenue grew through 2024 and has held roughly level since: $2.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | -0.9 points |
| Q1 2026 | 15% | -0.4 points |
| Q4 2025 | 14% | -5 points |
| Q3 2025 | 21% | +2.9 points |
| Q2 2025 | 18% | +2 points |
| Q1 2025 | 15% | +2.5 points |
| Q4 2024 | 19% | +4.4 points |
| Q3 2024 | 18% | +2 points |
GRFS's operating margin was 18% last quarter, down 0.9 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over GRFS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over GRFS on profitability, with a higher operating margin.
GRFS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $120M | +14% |
| Q1 2026 | $65.5M | -32% |
| Q4 2025 | $329.6M | -28% |
| Q3 2025 | $283.7M | +19% |
| Q2 2025 | $105.6M | -57% |
| Q1 2025 | $95.9M | +$321.4M |
| Q4 2024 | $460.5M | +444% |
| Q3 2024 | $239.2M | +203% |
GRFS generated $799M in free cash flow over the past year, down 11% from the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over GRFS on cash flow, with more consistent year-over-year improvement.
GRFS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.2% | -8M shares |
| 3 years | +0.3% | +2M shares |
| 5 years | +6.8% | +43.2M shares |
| Available history | -0.5% | -3.6M shares |
GRFS has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
GRFS hasn't bought back shares in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
GRFS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.6x | High |
| Q1 2026 | 5.4x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 5.6x | High |
| Q2 2025 | 5.0x | High |
| Q1 2025 | 6.2x | High |
| Q4 2024 | 6.3x | High |
| Q3 2024 | 6.5x | High |
GRFS's net debt is about 4.6 years of its operating earnings (EBITDA), down from 5.0 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over GRFS on leverage, with a lower net debt burden relative to earnings.
GRFS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.4 | Neutral |
| Stochastic | 84.5 | Overbought |
GRFS's weekly RSI is 65 (neutral) and its Stochastic is 85 (overbought).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
GRFS PE vs Healthcare Sector
| Metric | GRFS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GRFS has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
GRFS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.83 | 12% above |
| 20 week MA | $7.69 | 14% above |
| 50 week MA | $8.15 | 8% above |
| 100 week MA | $8.36 | 5.3% above |
| 200 week MA | $8.39 | 4.9% above |
GRFS has climbed back above all five of its weekly moving averages, and it's now 4.9% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
GRFS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $18.7 | -21% |
| 2021 | $18.7 | $11.2 | -40% |
| 2022 | $11.2 | $8.12 | -27% |
| 2023 | $8.12 | $11.6 | +42% |
| 2024 | $11.6 | $7.65 | -34% |
| 2025 | $7.65 | $9.10 | +19% |
| 2026 YTD | $9.10 | $8.80 | -3.3% |
GRFS has finished lower in four of the last six years. It's down 3.3% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over GRFS on returns for 2026, with the stronger performance.